For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, CARGO Therapeutics Inc (NASDAQ: CRGX) closed at $4.22 up 1.93% from its previous closing price of $4.14. In other words, the price has increased by $1.93 from its previous closing price. On the day, 0.58 million shares were traded. CRGX stock price reached its highest trading level at $4.311 during the session, while it also had its lowest trading level at $4.078.
Ratios:
For a deeper understanding of CARGO Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.30 and its Current Ratio is at 6.30. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
On January 30, 2025, Truist Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $32 to $7.
Piper Sandler Downgraded its Overweight to Neutral on January 30, 2025, whereas the target price for the stock was revised from $34 to $4.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 14 ’25 when Radhakrishnan Anup sold 27,404 shares for $3.84 per share. The transaction valued at 105,272 led to the insider holds 122,413 shares of the business.
Radhakrishnan Anup sold 1,629 shares of CRGX for $6,522 on Apr 03 ’25. The insider now owns 77,317 shares after completing the transaction at $4.00 per share. On Sep 18 ’24, another insider, Chapman Gina, who serves as the President & CEO of the company, sold 7,166 shares for $25.09 each. As a result, the insider received 179,775 and left with 103,905 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRGX now has a Market Capitalization of 194598544 and an Enterprise Value of -93791648.
Stock Price History:
The Beta on a monthly basis for CRGX is 0.29, which has changed by -0.74299634 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, CRGX has reached a high of $25.45, while it has fallen to a 52-week low of $3.00. The 50-Day Moving Average of the stock is -2.34%, while the 200-Day Moving Average is calculated to be -60.97%.
Shares Statistics:
For the past three months, CRGX has traded an average of 676.75K shares per day and 382180 over the past ten days. A total of 46.05M shares are outstanding, with a floating share count of 32.85M. Insiders hold about 28.77% of the company’s shares, while institutions hold 76.90% stake in the company. Shares short for CRGX as of 1749772800 were 3282311 with a Short Ratio of 4.85, compared to 1747267200 on 2595064. Therefore, it implies a Short% of Shares Outstanding of 3282311 and a Short% of Float of 8.2399994.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are keenly observing as 3.0 analysts analyze and rate the current performance of CARGO Therapeutics Inc (CRGX) in the stock market.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.37 and low estimates of -$0.53.
Analysts are recommending an EPS of between -$1.49 and -$2.34 for the fiscal current year, implying an average EPS of -$1.96. EPS for the following year is -$2.32, with 4.0 analysts recommending between -$1.66 and -$3.58.
